PROF

Profound Medical Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 2/10
  • Value↓ 0/10
Profound Medical sales and earnings growth
PROF Growth
Fair
  • Revenue Y/Y↑ 58.61%
  • EPS Y/Y↓ -3.33%
  • FCF Y/Y↓ -41.53%
Profound Medical gross and profit margin trends
PROF Profitability
Neutral
  • Gross margin ↑ 71.10%
  • EPS margin↓ -206.80%
  • ROIC 5Y↓ -210.82%
Profound Medical net debt vs free cash flow
PROF Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -39.6

Profound Medical stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Medical Devices stocks